Weaver RL - Search Results

1

Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.

Davis TA, Grillo-López AJ, White CA, McLaughlin P, Czuczman MS, Link BK, Maloney DG, Weaver RL, Rosenberg J, Levy R. Davis TA, et al. Among authors: weaver rl. J Clin Oncol. 2000 Sep;18(17):3135-43. doi: 10.1200/JCO.2000.18.17.3135. J Clin Oncol. 2000. PMID: 10963642 Clinical Trial.

2

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.

Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-López AJ. Czuczman MS, et al. J Clin Oncol. 2004 Dec 1;22(23):4711-6. doi: 10.1200/JCO.2004.04.020. Epub 2004 Oct 13. J Clin Oncol. 2004. PMID: 15483015 Clinical Trial.

3

Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab.

Davis TA, White CA, Grillo-López AJ, Velásquez WS, Link B, Maloney DG, Dillman RO, Williams ME, Mohrbacher A, Weaver R, Dowden S, Levy R. Davis TA, et al. J Clin Oncol. 1999 Jun;17(6):1851-7. doi: 10.1200/JCO.1999.17.6.1851. J Clin Oncol. 1999. PMID: 10561225 Clinical Trial.

4

Antibody-targeted immunotherapy for treatment of malignancy.

White CA, Weaver RL, Grillo-López AJ. White CA, et al. Among authors: weaver rl. Annu Rev Med. 2001;52:125-45. doi: 10.1146/annurev.med.52.1.125. Annu Rev Med. 2001. PMID: 11160771 Review.

5

Rituximab: the first monoclonal antibody approved for the treatment of lymphoma.

Grillo-López AJ, White CA, Dallaire BK, Varns CL, Shen CD, Wei A, Leonard JE, McClure A, Weaver R, Cairelli S, Rosenberg J. Grillo-López AJ, et al. Curr Pharm Biotechnol. 2000 Jul;1(1):1-9. doi: 10.2174/1389201003379059. Curr Pharm Biotechnol. 2000. PMID: 11467356 Review.

6

Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma.

Grillo-López AJ, Dallaire BK, McClure A, Weaver R, Varns C, Wei A, Allen R, Lee D, Shen D, Leonard J, Multani P, White CA. Grillo-López AJ, et al. Curr Pharm Biotechnol. 2001 Dec;2(4):301-11. doi: 10.2174/1389201013378563. Curr Pharm Biotechnol. 2001. PMID: 11762412 Review.

7

Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab.

Czuczman MS, Grillo-López AJ, Alkuzweny B, Weaver R, Larocca A, McLaughlin P. Czuczman MS, et al. Leuk Lymphoma. 2006 Sep;47(9):1830-40. doi: 10.1080/10428190600709523. Leuk Lymphoma. 2006. PMID: 17064996 Clinical Trial.

8

Slow dynamic elasticity at short times.

Lee S, Weaver RL. Lee S, et al. Among authors: weaver rl. Phys Rev E. 2024 Jun;109(6-2):065002. doi: 10.1103/PhysRevE.109.065002. Phys Rev E. 2024. PMID: 39021003

9

Slow dynamics in a single bead with mechanical conditioning and transient heating.

Weaver RL, Lee S. Weaver RL, et al. Phys Rev E. 2023 Apr;107(4-1):044902. doi: 10.1103/PhysRevE.107.044902. Phys Rev E. 2023. PMID: 37198830

10

Diffuse energy transport and coda-wave interferometry for resonant transmission between reverberant structures.

Weaver RL, Lee S. Weaver RL, et al. J Acoust Soc Am. 2021 Aug;150(2):830. doi: 10.1121/10.0005758. J Acoust Soc Am. 2021. PMID: 34470299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters